MedPacto, Inc. (235980.KQ)

KRW 4585.0

(-1.4%)

Long Term Debt Summary of MedPacto, Inc.

MedPacto, Inc.'s latest annual long term debt in 2023 was 1.68 Billion KRW , down -30.38% from previous year.
MedPacto, Inc.'s latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
MedPacto, Inc. reported annual long term debt of 2.42 Billion KRW in 2022, down -95.22% from previous year.
MedPacto, Inc. reported annual long term debt of 50.7 Billion KRW in 2021, up 31693.26% from previous year.
MedPacto, Inc. reported quarterly long term debt of 1.6 Billion KRW for 2024 Q1, down 0.0% from previous quarter.
MedPacto, Inc. reported quarterly long term debt of - KRW for 2023 Q3, down -100.0% from previous quarter.

Annual Long Term Debt Chart of MedPacto, Inc. (2023 - 2017)

Historical Annual Long Term Debt of MedPacto, Inc. (2023 - 2017)

Year	Long Term Debt	Long Term Debt Growth
2023	1.68 Billion KRW	-30.38%
2022	2.42 Billion KRW	-95.22%
2021	50.7 Billion KRW	31693.26%
2020	159.48 Million KRW	0.0%
2019	- KRW	-100.0%
2018	1.59 Billion KRW	9.21%
2017	1.46 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- KRW	0.0%
2024 Q1	1.6 Billion KRW	0.0%
2023 Q3	- KRW	-100.0%
2023 FY	1.68 Billion KRW	-30.38%
2023 Q4	1.68 Billion KRW	0.0%
2023 Q2	2.13 Billion KRW	0.0%
2023 Q1	- KRW	-100.0%
2022 Q4	2.42 Billion KRW	0.0%
2022 Q2	- KRW	0.0%
2022 FY	2.42 Billion KRW	-95.22%
2022 Q1	- KRW	-100.0%
2022 Q3	- KRW	0.0%
2021 Q4	75.41 Billion KRW	3.35%
2021 Q1	- KRW	0.0%
2021 Q2	71.21 Billion KRW	0.0%
2021 FY	50.7 Billion KRW	31693.26%
2021 Q3	72.96 Billion KRW	2.46%
2020 Q4	- KRW	0.0%
2020 FY	159.48 Million KRW	0.0%
2019 FY	- KRW	-100.0%
2018 FY	1.59 Billion KRW	9.21%
2017 FY	1.46 Billion KRW	0.0%

Peer Long Term Debt Comparison of MedPacto, Inc.

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	90.593%
iNtRON Biotechnology, Inc.	258.29 Million KRW	-553.109%
BINEX Co., Ltd.	5.57 Billion KRW	69.759%
Bioneer Corporation	12.5 Billion KRW	86.504%
Anterogen.Co.,Ltd.	- KRW	-Infinity%
MEDIPOST Co., Ltd.	6.99 Billion KRW	75.883%
CrystalGenomics, Inc.	29.88 Billion USD	94.356%
Helixmith Co., Ltd	151.68 Million KRW	-1012.174%
Chabiotech Co.,Ltd.	95.06 Billion KRW	98.226%
Medy-Tox Inc.	1.22 Billion KRW	-37.615%
Peptron, Inc.	4.5 Billion KRW	62.512%
Amicogen, Inc.	70.65 Billion KRW	97.612%
Genexine, Inc.	22.68 Billion KRW	92.562%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	8.328%
LegoChem Biosciences, Inc.	528.37 Million KRW	-219.272%
ALTEOGEN Inc.	1.24 Billion KRW	-35.036%
PharmaResearch Co., Ltd.	970.71 Million KRW	-73.783%
SillaJen, Inc.	8.13 Billion KRW	79.265%
JETEMA, Co., Ltd.	60 Billion KRW	97.188%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	95.229%
Genomictree Inc.	97.51 Million KRW	-1629.923%
D&D Pharmatech	5.12 Billion KRW	67.056%
EASY BIO,Inc.	30 Billion KRW	94.377%
GI Innovation, Inc.	2.9 Billion KRW	41.91%